Quimioterapia de elección tras hormonoterapia en cáncer de mama metastásico - page 29

Bevacizumab combinations in 1L MBC

1L BV+CT for HER2- MBC: pooled & subgroup analyses (2447 pts data) & TURANDOT: finding ”subgroups”

Miles et al Ann Oncol 2013; Brodowicz et al BJC 2014

TNBC

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,19,20,21,22,23,24,25,26,27,28 30,31,32,33,34,35,36